z-logo
open-access-imgOpen Access
Identification and characterization of haemofungin, a novel antifungal compound that inhibits the final step of haem biosynthesis
Author(s) -
Dafna Ben Yaakov,
Anna Rivkin,
Gabriel Mircus,
Nathaniel D. Albert,
Anna-Maria Dietl,
Dimitry Kovalerchick,
Shmuel Carmeli,
Hubertus Haas,
Dimitrios P. Kontoyiannis,
Nir Osherov
Publication year - 2016
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkv446
Subject(s) - aspergillus fumigatus , biology , microbiology and biotechnology , aspergillus nidulans , galleria mellonella , in vivo , biochemistry , virulence , mutant , gene
During recent decades, the number of invasive fungal infections among immunosuppressed patients has increased significantly, whereas the number of effective systemic antifungal drugs remains low and unsatisfactory. The aim of this study was to characterize a novel antifungal compound, CW-8/haemofungin, which we previously identified in a screen for compounds affecting fungal cell wall integrity.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom